ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
TransMedics Group Inc

TransMedics Group Inc (TMDX)

66.95
1.42
(2.17%)
마감 31 1월 6:00AM
67.9422
0.9922
(1.48%)
시간외 거래: 8:49AM

행사 가격매수가매도가최근 가격중간 가격가격 변동가격 변동 %거래량미결제 약정최근 거래
35.0030.0033.8022.1531.900.000.00 %02-
40.0025.2029.0024.0027.100.000.00 %08-
45.000.000.000.000.000.000.00 %00-
50.000.000.000.000.000.000.00 %00-
55.0012.5013.2013.5012.852.2019.47 %43731/01/2025
60.000.000.000.000.000.000.00 %00-
65.000.000.000.000.000.000.00 %00-
70.003.303.603.383.450.185.63 %2321,27731/01/2025
75.001.952.102.202.0250.2010.00 %10972631/01/2025
80.000.000.000.000.000.000.00 %00-
85.000.000.000.000.000.000.00 %00-
90.000.300.450.400.3750.038.11 %2124731/01/2025
95.000.000.000.000.000.000.00 %00-
100.000.150.200.200.1750.0533.33 %528631/01/2025

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

행사 가격매수가매도가최근 가격중간 가격가격 변동가격 변동 %거래량미결제 약정최근 거래
35.000.000.000.000.000.000.00 %00-
40.000.200.250.060.225-0.14-70.00 %511131/01/2025
45.000.050.250.150.15-0.10-40.00 %752931/01/2025
50.000.000.000.000.000.000.00 %00-
55.000.000.000.000.000.000.00 %00-
60.000.000.000.000.000.000.00 %00-
65.003.503.803.803.65-0.50-11.63 %211,51931/01/2025
70.006.306.806.306.55-1.02-13.93 %620231/01/2025
75.000.000.000.000.000.000.00 %00-
80.0013.8014.4013.3614.10-6.74-33.53 %15331/01/2025
85.000.000.000.000.000.000.00 %00-
90.000.000.000.000.000.000.00 %00-
95.000.000.000.000.000.000.00 %00-
100.0031.2035.100.0033.150.000.00 %00-

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
FOXXFoxx Development Holdings Inc
US$ 6.355
(119.90%)
33.52M
BHILBenson Hill Inc
US$ 3.925
(118.06%)
13.52M
TECXTectonic Therapeutic Inc
US$ 55.18
(114.54%)
5.46M
AMODAlpha Modus Holdings Inc
US$ 3.2299
(109.73%)
125.47M
DOMHDominari Holdings Inc
US$ 3.61
(59.03%)
4.24M
CLEUChina Liberal Education Holdings Ltd
US$ 0.149
(-98.08%)
311.38M
CRGXCARGO Therapeutics Inc
US$ 3.39
(-74.30%)
21.21M
TDTHTrident Digital Tech Holdings Ltd
US$ 1.0159
(-58.87%)
2.46M
EVTVEnvirotech Vehicles Inc
US$ 0.338202
(-49.30%)
4.78M
IRWDIronwood Pharmaceuticals Inc
US$ 2.29
(-38.44%)
10.53M
NVDANVIDIA Corporation
US$ 124.65
(0.77%)
392.11M
CLEUChina Liberal Education Holdings Ltd
US$ 0.149
(-98.08%)
311.38M
MGOLMGO Global Inc
US$ 0.1199
(17.90%)
166.88M
SPGCSacks Parente Golf Inc
US$ 0.93
(57.63%)
129.08M
RIMEAlgorhythm Holdings Inc
US$ 0.02465
(-5.19%)
126.09M

TMDX Discussion

게시물 보기
Monksdream Monksdream 9 월 전
TMDX new 52+ week high
👍️0
Monksdream Monksdream 11 월 전
TMDX 10Q
👍️0
make it happen make it happen 1 년 전
Should touch $50 net lose widens, and has a 40% day. The structure shows over 100% ownership which technically should be illegal. How can there be over 100%? Imho mean institutions and whomever will be selling for a 40%ish profit overnight.
👍️0
crudeoil24 crudeoil24 4 년 전
TransMedics Late Tuesday Announced FDA Advisory Committee Panel Voted 12 To 5 That Benefits Of OCS Heart System Outweigh Risks
6:58 am ET April 7, 2021 (Benzinga) Print
TransMedics Group, Inc. ("TransMedics") (NASDAQ:TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that after the review of TransMedics' clinical evidence from the OCS Heart EXPAND trial, the associated Continued Access Protocol ("CAP") results, as well as the OCS Heart PROCEED II trial, the Circulatory Systems Device Advisory Panel convened by the U.S. Food and Drug Administration ("FDA") has issued a favorable vote in support of approval of the OCS Heart System to the FDA's Office of Health Technology 2 (Cardiovascular Devices). The panel voted 12 to 5, with 1 abstaining, that the benefits of the OCS Heart System outweigh its risks. The panel voted 10 to 6, with 2 abstaining, that there is reasonable assurance that the OCS Heart System is effective. The panel voted 9 to 7, with 2 abstaining, that there is reasonable assurance of the OCS Heart System's safety.

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
👍️0
crudeoil24 crudeoil24 4 년 전
Transmedics group, Inc. is a commercial-stage medical technology company. It is focused on developing organ transplant therapy for end-stage organ failure patients across multiple disease states. The Company has designed and developed organ care system (OCS) a portable organ perfusion, optimization and monitoring system that utilizes customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It has developed three OCS products, one for each of lung, heart and liver transplantations. Its OCS clinical programs include OCS Lung INSPIRE Trial, OCS Lung Expand Trial, OCs Heart EXPAND and PROCEED II Trials. Its organ care system (OCS) technology platform to perfuse donor organs with warm, oxygenated, nutrient-enriched blood, while maintaining the organs in a living, functioning state; the lung is breathing, the heart is beating and the liver is producing bile. It is also focused on developing additional OCS products for kidney transplantation.
👍️0

최근 히스토리

Delayed Upgrade Clock